Trial Profile
A Double-Blind Crossover Study in Healthy Volunteers to Compare Two Formulations of Proellex for Oral Administration
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 05 Sep 2014
Price :
$35
*
At a glance
- Drugs Telapristone (Primary)
- Indications Breast cancer; Endometriosis; Uterine leiomyoma
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Repros Therapeutics
- 02 Sep 2014 Status changed from recruiting to completed, as per ClinicalTrials.gov record.
- 21 May 2014 New trial record